Press Releases

Press Releases

January 4, 2023

Biolog Acquires MIDI

The world of Biolog gets Bigger! Biolog adds contract services and new analysis software to its portfolio of tools with the acquisition of MIDI Labs and MIDI, Inc. January 4, 2023 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI Labs...
Read More
November 16, 2022

Biolog responds to customer demands for custom Phenotype MicroArrays with a resounding “YES”

November 16, 2022 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial phenotypic profiling and identification products, including the company’s high-throughput OmniLog® system, today announced the launch of new customizable Phenotype MicroArrays™ to further assist Biolog’s customers with metabolic profiling of microbial, mammalian, as well as yeast and fungi cells. Phenotype MicroArrays...
Read More
May 12, 2022

Biolog Announces New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products

Biolog Announces New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products May 12, 2022 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling technologies, today announced the appointment of a new leadership team including industry veteran Robert Wicke...
Read More
August 14, 2020

Discovery of activation of cancer-fighting T cells by inosine, enabled by Biolog metabolic assay technology

Discovery of activation of cancer-fighting T cells by inosine, enabled by Biolog metabolic assay technology Hayward, CA, USA – August 14, 2020 – A multi-site research team headed by Dr. Ruoning Wang at the Nationwide Children’s Hospital has uncovered a metabolic pathway that can potentially be exploited to enhance the killing of anti-cancer T cells...
Read More
February 13, 2019

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology Discovery could open doorway to new treatment Sheffield, UK and Hayward, CA, USA –February 13, 2019–Researchers at the University of Sheffield have identified a new pathway that is disrupted in amyotrophic lateral sclerosis (ALS), a debilitating and ultimately lethal motor neuron disease (MND). The...
Read More
January 16, 2018

Mitochondrial assay breakthrough announced by Biolog

Hayward, CA – January 16, 2018 – Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial function has, for many years, been on the wish list of researchers studying a wide range of human disorders. The new products, MitoPlate™ S-1 and...
Read More
November 13, 2017

Biolog granted patent on novel treatment for Clostridium difficile infection – seeks commercial partner

Hayward, CA – November 13, 2017 – Biolog, Inc. announced today that it has been granted US Patent 9,662,372 describing a new potential approach for treating life-threatening infections by the colon residing bacterium, Clostridium difficile (recently renamed as Peptoclostridium difficile). The patent describes the discovery by Biolog scientists that cationic compounds can rapidly inactivate the toxin produced by this...
Read More
April 3, 2017

Biolog expands its GEN III Bacterial Identification Database with Plant Pathogens

Hayward, CA – April 3, 2017 – Biolog, Inc. announced today details of its latest GEN III identification database version 2.8, containing 1568 taxa, including 258 plant pathogens. This database update was completed by scientists at Biolog’s headquarters in Hayward, CA in collaboration with Dr. Bevan Weir and his colleagues at Landcare Research in Auckland, New...
Read More